Johnson Craig A 4
4 · Mirati Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Johnson Craig A
Director
Transactions
- Award
Common Stock
2023-12-29$58.75/sh+6,808$399,970→ 17,273 total
Footnotes (1)
- [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.